23andMe, Moving Beyond Consumer DNA Tests, Is Building a Clinical Trial Recruitment Business

September 26, 2019

(STAT News) – Consumer genetics giant 23andMe announced Thursday that it would move deeper into the business of clinical trial recruitment, partnering with a fast-growing startup to help match its customers with nearby study sites based on their diseases, demographics, and DNA. The Silicon Valley company has for months been quietly making inroads into clinical trial recruitment by emailing customers who’ve opted in with recommendations about studies that might be appropriate for them.

Recommended Reading